NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment in USD from Q1 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2011 to Q1 2023.
  • Navidea Biopharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2023 was $15.1K, a 64.1% decline year-over-year.
  • Navidea Biopharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the twelve months ending March 31, 2023 was $36.1K, a 46.3% decline year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $63.1K, a 150% increase from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $25.2K, a 81.4% decline from 2020.
  • Navidea Biopharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2020 was $136K, a 10701% increase from 2019.
Payments to Acquire Property, Plant, and Equipment, Trailing 12 Months (USD)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $36.1K $15.1K -$26.9K -64.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $63.1K -$42K -$46.5K -1040% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-27
Q3 2022 $110K $14.4K -$3.61K -20% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $113K $48.7K +$46K +1697% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $67.2K $42K +$42K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $25.2K $4.47K -$2.2K -32.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $27.4K $18K -$103K -85.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $130K $2.71K +$760 +39% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $129K $0 -$6.46K -100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $136K $6.67K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $121K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.95K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $6.46K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2018 $16.2K -$7.1K -30.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $3.17K -$5.01K -61.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q4 2017 $33.7K $2.27K +$5.97K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 $27.7K $23.2K +$21.4K +1159% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $6.32K $8.17K +$6.32K +342% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $0 $0 -$1.85K -100% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $1.85K -$3.69K -$12.3K -143% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $14.1K $1.85K -$941 -33.8% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $15.1K $1.85K -$25.8K -93.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $40.8K $1.85K +$1.85K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $39K $8.6K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 $2.79K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $27.6K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $0 -$986K -100% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q1 2014 $986K +$630K +177% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $355K +$214K +151% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q1 2012 $141K +$84.8K +150% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $56.6K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.